Amgen & UCB ‘s Romosozumab: Development Pathway and approval status
Amgen and UCB, a global biopharmaceutical company, announced the resubmission of the Biologics License Application (BLA) to the US Food and Drug... Read More
Lannett has acquired Kremers Urban Pharmaceuticals for around US$1.23 billion
Pharma manufacturer Lannett has completed its ‘transformational acquisition’ of Kremers Urban Pharmaceuticals for around US$1.23 billion. Lannett has acquired KU from global... Read More